Thumbnail Image
Publication

Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?

Adderley, Helen
; 
Ackermann, Christoph J
; 
Califano, Raffaele
Citations
Altmetric:
Abstract
Comment on Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial. [Lancet Oncol. 2019]
Authors
Adderley, Helen
Ackermann, Christoph J
Califano, Raffaele
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
Description
Date
2020
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 161.87 KB
Keywords
Type
Article
Citation
Adderley H, Ackermann CJ, Califano R. Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line? Ann Transl Med. 2019;7(Suppl 8):S346.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622785
Embedded videos